Healthpeak Properties (NYSE:DOC) Reaches New 1-Year High – Here’s What Happened

Healthpeak Properties, Inc. (NYSE:DOC) reached a new 52-week high on Tuesday . The stock traded as high as $22.81 and last traded at $22.8180, with a volume of 2223794 shares. The stock had previously closed at $22.52.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on DOC. Raymond James Financial initiated coverage on Healthpeak Properties in a report on Wednesday, June 17th. They issued a “market perform” rating for the company. Wells Fargo & Company lifted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a report on Wednesday, July 15th. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Robert W. Baird increased their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Finally, UBS Group raised their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Four equities research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Hold” and an average price target of $20.62.

Healthpeak Properties Price Performance

The stock has a market capitalization of $15.76 billion, a PE ratio of 71.50, a P/E/G ratio of 3.46 and a beta of 1.02. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock’s 50-day moving average is $20.80 and its 200 day moving average is $18.51.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. During the same quarter in the prior year, the firm earned $0.46 EPS. The company’s revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, equities analysts predict that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be paid a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a dividend yield of 5.3%. Healthpeak Properties’s dividend payout ratio is 381.25%.

Insider Activity

In related news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the sale, the insider directly owned 7,636 shares in the company, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.23% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of DOC. State Street Corp increased its position in Healthpeak Properties by 1.8% in the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after purchasing an additional 895,460 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Healthpeak Properties by 8.6% during the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after buying an additional 2,438,278 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Healthpeak Properties by 19.2% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after buying an additional 4,776,056 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Healthpeak Properties by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock valued at $312,959,000 after buying an additional 123,274 shares during the last quarter. Finally, Invesco Ltd. grew its stake in shares of Healthpeak Properties by 9.9% in the 4th quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock valued at $294,244,000 after buying an additional 1,648,012 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.